|
SCYL2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.15939999999426E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.63660000000099E-05 |
| Normal-vs-Stage2 |
1.183840E-02 |
| Normal-vs-Stage3 |
1.869790E-01 |
| Normal-vs-Stage4 |
3.634400E-02 |
| Stage1-vs-Stage2 |
9.075600E-01 |
| Stage1-vs-Stage3 |
1.741990E-01 |
| Stage1-vs-Stage4 |
6.738000E-01 |
| Stage2-vs-Stage3 |
3.282000E-01 |
| Stage2-vs-Stage4 |
6.093800E-01 |
| Stage3-vs-Stage4 |
2.263600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.63030000000153E-05 |
| Normal-vs-AfricanAmerican |
6.142300E-03 |
| Normal-vs-Asian |
6.216000E-01 |
| Caucasian-vs-AfricanAmerican |
6.082800E-01 |
| Caucasian-vs-Asian |
5.328400E-01 |
| AfricanAmerican-vs-Asian |
6.635000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.44170000004884E-06 |
| Normal-vs-Female |
2.628800E-01 |
| Male-vs-Female |
7.802500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.524250E-03 |
| Normal-vs-Extreme_Weight |
5.72249999608587E-08 |
| Normal-vs-Obese |
2.174300E-02 |
| Normal-vs-Extreme_Obese |
5.204200E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.689400E-01 |
| Normal_Weight-vs-Obese |
2.641200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.077600E-01 |
| Extreme_Weight-vs-Obese |
1.466310E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.838800E-01 |
| Obese-vs-Extreme_Obese |
4.282600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.464600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.802700E-03 |
| Normal-vs-Age(61-80Yrs) |
4.8596999999706E-06 |
| Normal-vs-Age(81-100Yrs) |
2.05839999999347E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.263400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.379600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.812280E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.064000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.558200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.258600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.55960000000921E-06 |
| Normal-VS-Type2 PRCC |
4.139200E-03 |
| Normal-VS-KIRP CIMP |
9.458400E-01 |
| Normal-VS-Unclassified PRCC |
4.045400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.926600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.573900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.364400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.211400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.374200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.907200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.35589999999508E-05 |
| Normal-vs-N1 |
8.153400E-01 |
| Normal-vs-N2 |
5.107400E-01 |
| N0-vs-N1 |
1.136320E-02 |
| N0-vs-N2 |
5.470800E-01 |
| N1-vs-N2 |
5.754400E-01 |
|
|
